Alternatives to Ipilimumab
Ipilimumab is a Immunotherapy tool: ipilimumab is a monoclonal antibody used in cancer immunotherapy, primarily targeting CTLA-4 to activate the immune system against cancer cells. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Immunotherapy companies to Ipilimumab
- Website
Signadori Bio45BiotechnologyParis, France$12.2MDeveloping a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.
- Website
BioNTech66BiotechnologyMainz, Germany$975.0MGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website
Enterome60BiotechnologyParis, France$123.9MClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
- Website
Gilboa Therapeutics43BiopharmaceuticalsTel Aviv, IsraelPreclinical biopharma developing next-gen cancer immunotherapies using proprietary SolidT technology.
- Website
KaliVir Immunotherapeutics, Inc.57BiotechnologyPittsburgh, United States$14.0MClinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
- Website
Janux Therapeutics57BiotechnologySan Diego, USA$181.0MA clinical-stage biopharmaceutical company developing novel immunotherapies.
- Website
Curesponse55Life SciencesTel Aviv, Israel$28.0MPersonalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.
- Website CRCrossbow Therapeutics55BiotechnologyCambridge, United States$157.0M
Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.
- Website
Tharimmune53BiotechCambridge, United States$540.0MBiotechnology company developing novel immunotherapies for cancer.
- Website
Leo Cancer Care53HealthTechMiddleton, USA$65.0MReinventing cancer imaging and treatment through upright patient positioning.
- Website
Pyxis Diagnostics51HealthcareSan Diego, United States$10.0MDeveloping novel diagnostics to predict patient response to immunotherapy.
- Website
LTZ Therapeutics49BiotechnologyRedwood City, USA$76.0MImmunotherapy company targeting oncology and autoimmune diseases.
- Website
Adicet Bio48BiotechBoston, United States$389.0MClinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
- Website
Brenus Pharma48BiotechnologyLyon, France$12.6MClinical-stage immunotherapy company developing novel treatments for cancer.
- Website LELeman Biotech48BiotechShenzhen, China$22.7M
Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.
- Website GEGenexine47BiotechnologySeoul, South Korea$296.5M
South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.
- Website
ImmunityBio44BiotechnologyCulver City, USA$75.0MA commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Mabylon35BiotechGeneva, Switzerland$35.8MMabylon is a biotechnology company focused on developing innovative antibody-based therapies for infectious diseases and cancer.
Showing the 20 closest matches. See the rest on the Ipilimumab profile.